Liquid Chromatography Evaluation of a Novel Graphitic Carbon Stationary Phase Using Glucagon-Like Peptide‑1 Analogs

Liquid Chromatography Evaluation of a Novel Graphitic Carbon Stationary Phase Using Glucagon-Like Peptide‑1 Analogs

Saved in:

Bibliographic Details
Main Authors:	Michael Jack Parente, Balaji Sitharaman
Format:	Article
Language:	English
Published:	American Chemical Society 2025-08-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.5c02172
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Investigation of russian organosilicon stationary phases for gas-liquid chromatography
by: G. N. Turkeltaub, et al.
Published: (2008-02-01)

The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

Enantioseparation of Secnidazole by High-Performance Liquid Chromatography Using Amylose-Based Stationary Phase
by: Ana C. Nascimento, et al.
Published: (2012-09-01)

Glucagon-Like Peptide-1 Analog Liraglutide Protects against Diabetic Cardiomyopathy by the Inhibition of the Endoplasmic Reticulum Stress Pathway
by: Jieyu Liu, et al.
Published: (2013-01-01)

Physiology and pharmacology of glucagon-like peptide-1 receptor
by: D. V. Kurkin, et al.
Published: (2024-01-01)

Toward Personalized Stationary Chromatography Phases: Equipping Commercial Silica Phases with Selected Peptide‐Based Binding Domains to Tailor Affinity
by: Steffen A. Busche, et al.
Published: (2025-06-01)

Nephroprotective potential of glucagon-like peptide-1 receptor agonists
by: Minara S. Shamkhalova, et al.
Published: (2020-04-01)

Bioactivity of a modified human Glucagon-like peptide-1.
by: Fangfang Xu, et al.
Published: (2017-01-01)

Glucagon‐like peptide‐1 receptor agonists and kidney outcomes
by: Richard J. MacIsaac, et al.
Published: (2024-10-01)

Recommendations for selection of a liquid stationary phase and geometric parameters of the column when determining triethylamine by gas chromatography
by: A. N. Ioutsi, et al.
Published: (2018-02-01)

Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?
by: Matthias Ploug Larsen, et al.
Published: (2017-01-01)

Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatology
by: Е. L. Nasonov, et al.
Published: (2024-04-01)

Therapeutic strategies, consequences and prospects of glucagon-like peptide-1 agonists
by: N.M. Bobok
Published: (2025-05-01)

Glucagon-Like Peptide-1 Is Prognostic of Mortality in Acute Respiratory Failure
by: Cole E. Hansell, MD, et al.
Published: (2025-04-01)

P3. Unveiling Weight Loss Trends and Complications in Body Contouring Surgery Among Glucagon Like Peptide Analogs Users: An Eight Year Experience
by: Alejandra Aristizábal, MD, et al.
Published: (2025-05-01)

In Situ Synthesis of Hypercrosslinked Polymer as Stationary Phase for Capillary Gas Chromatography
by: Yan Wu, et al.
Published: (2024-11-01)

Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges
by: Zhi Dong Zhou, et al.
Published: (2025-06-01)

Thermal and Hydrothermal Treatment of Silica Gels as Solid Stationary Phases in Gas Chromatography
by: Ashraf Yehia El-Naggar
Published: (2013-01-01)

Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
by: Hideaki Jinnouchi, et al.
Published: (2015-01-01)

Methylation status of vault RNA 2-1 promoter is a predictor of glycemic response to glucagon-like peptide-1 analog therapy in type 2 diabetes mellitus
by: Chia-Hung Lin, et al.
Published: (2021-03-01)

Efficacy of Dual Glucagon and Glucagon-like Peptide-1 Receptor Agonists Across the Cardiometabolic Continuum: A Review of Current Clinical Evidence
by: Panagiotis Stachteas, et al.
Published: (2025-07-01)

Multiomics insight into the role of glucagon‐like peptide‐1 receptor agonists in heart failure
by: Yuhang Tao, et al.
Published: (2025-08-01)

Patient-reported outcomes of glucagon-like peptide-1 agonists on hidradenitis suppurativa severity
by: Radhika Gupta, BA, et al.
Published: (2025-08-01)

Mechanism of glucagon-like peptide-1 receptor agonist in the treatment of obesity and food addiction
by: LIU Luyao, LI Linwei, WANG Chen, DI Jianzhong
Published: (2025-06-01)

The Effect of Glucagon-Like Peptide-2 Receptor Agonists on Colonic Anastomotic Wound Healing
by: Heather A. Redstone, et al.
Published: (2010-01-01)

Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists
by: Rui Song, et al.
Published: (2022-01-01)

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
by: Gagik R. Galstyan, et al.
Published: (2017-10-01)

The current and changing role of glucagon-like peptide-1 receptor agonists in knee osteoarthritis
by: Anne D. Holleman, et al.
Published: (2025-09-01)

The therapeutic effects and mechanisms of glucagon-like peptide-1 receptor agonists in neurocognitive disorders
by: Junchen Si, et al.
Published: (2025-04-01)

Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Mechanisms, Efficacy, and Safety
by: Michał Stasiak, et al.
Published: (2025-06-01)

Research progress on mechanisms of glucagon-like peptide-1 receptor agonists in diabetic retinopathy
by: HE Cuihuan, SHI Derong, SUN Dandan, LI Yurui, XIA Guanghao
Published: (2025-02-01)

Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review
by: Aleksander Jentkiewicz, et al.
Published: (2025-02-01)

Glucagon‐Like Peptide‐1 Receptor Agonists and Anesthesia—Are We Clearer on the Correct Approach?
by: Zachary Bloomgarden
Published: (2024-12-01)

Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients
by: Luis Alberto Vigara, et al.
Published: (2024-11-01)

Successful Pregnancy in a Patient with Crohn’s Disease and Short Bowel Syndrome: Off Total Parenteral Nutrition and On Teduglutide, a Glucagon-Like Peptide-2 Analog – A Case Report
by: Maria M. Dahar, et al.
Published: (2025-02-01)

Association of Glucagon‐Like Peptide Agonist Therapy With Dietary Patterns in a Cross‐Sectional Cohort
by: Eric J. Brandt, et al.
Published: (2025-06-01)

The Effects of Sleeve Gastrectomy on Glucose Metabolism and Glucagon-Like Peptide 1 in Goto-Kakizaki Rats
by: Laiyuan Li, et al.
Published: (2018-01-01)

Glucagon-Like Peptide-1 (GLP-1) during Ramadan: Narrative Review of the Published Literature
by: Khalid Mohammed Alayed
Published: (2023-01-01)

Glucagon-like peptide-1 receptor modulates cerebrospinal fluid secretion and intracranial pressure in rats
by: Mette N. Jensen, et al.
Published: (2025-04-01)

Health Disparity Clusters of Off Label Prescriptions for Glucagon-Like Peptide 1 Receptor Agonists
by: Kateri J. Spinelli, et al.
Published: (2025-06-01)